With more people turning to their smartphones to complement their medical care, and the number of apps flooding the marketplace, how can a new consumer health app catch the attention of investors?Continue reading
Category Archives: AZBio News
Amgen And Allergan’s MVASI™ (bevacizumab-awwb) And KANJINTI™ (trastuzumab-anns) Now Available In The United States
First Biosimilar Avastin® and Herceptin® Products to Launch in the United StatesContinue reading
PathogenDx and Nationwide Laboratory Services Announce a Strategic Partnership to Deploy Ultra-Rapid Molecular Pathology for Rapid Strain Identification
Breakthrough in Clinical Diagnostics for Medical Microbial Testing in the Dermatology and Podiatric Fungal Markets
Eric Gilbertson Advocacy Institute for Behavioral Health Accepting Applications for 2019 Program
The Arizona Behavioral Health Corporation is accepting applications for the 2019 Eric Gilbertson Advocacy Institute for Behavioral Health. The program includes six days of advocacy training and a comprehensive overview of Arizona’s behavioral health systemContinue reading
Dr. Michael M.I. Abecassis Appointed Dean Of UA College of Medicine – Tucson
Dr. Abecassis is the J. Roscoe Miller Distinguished Professor of Surgery and Microbiology-Immunology at the Feinberg School of Medicine at Northwestern University. He also is chief of the Division of Organ Transplantation and founding director of the Comprehensive Transplant Center.Continue reading
HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, announced the release of its HTG EdgeSeqTM Reveal data analytics software, version 1.2.0. HTG EdgeSeq Reveal is a powerful software product that can enable customers to streamline their analysis of samples processed on the HTG EdgeSeq platform.Continue reading
AZBio Earns GuideStar’s Highest Seal of Transparency
Platinum Seal Allows Donors to Focus on Progress and Results
Continue reading
Noted Oncologist Dr. William Cance Named Interim Director of UA Cancer Center
The appointment was made by UA Senior Vice President for Health Sciences Michael D. Dake, MD.
“Dr. Cance has made enormous strides in Phoenix and across the state to establish a culture of collaboration to advance cancer care and treatment,” Dr. Dake said. “His keen focus on collaboration will enhance programs, advance basic science, reduce disparities and elevate the UA Cancer Center’s reputation for excellence in service to our state.”Continue reading